Welcome!

News Feed Item

Proteus Digital Health™, NHS England and UK Trade & Investment to Bring Transformative Digital Health Technology to the UK

Leading digital medicines company Proteus Digital Health™ is partnering with Eastern Academic Health Science Network (EAHSN), The Northern Health Science Alliance (NHSA) and Oxford University, Oxford University Hospitals NHS Trust and Oxford Academic Health Science Network (OAHSN) to bring digital health technology and global operations and manufacturing to the UK.

Each of the organisations will team up with Proteus Digital Health™ to assess the value of digital medicines in supporting patients’ medication taking behaviours and daily activity while realising significant cost savings.

Proteus Digital Health™ intends to employ 200 highly skilled individuals at its first international manufacturing site in the UK. The international manufacturing facility will serve as a new hub for the global digital medicines industry, transferring significant investment and know-how to the UK.

“I’m delighted that Proteus Digital Health is establishing their first international manufacturing site here in Britain, creating 200 highly skilled jobs,” said Prime Minister David Cameron. “It’s proof that our work to attract high-tech business to the UK is providing real benefits for people at home – all part of our long term economic plan.”

The partnership was facilitated by NHS England and the Life Science Investment Organisation (LSIO) of UK Trade & Investment (UKTI). “This partnership will clearly benefit patients, the NHS and the economy,” said Miles Ayling, Director of Innovation at NHS England.

"Our lives are becoming increasingly digital, a variety of sectors have already undergone fundamental changes through the introduction of innovative digital approaches,” said Dr. Hakim Yadi, Chief Executive Officer of the Northern Health Science Alliance. “Healthcare is clearly the next sector to benefit from such changes and we are delighted to be working with Proteus to pioneer the use of this technology at scale in the North of England to the benefit of patients and the NHS."

Proteus Digital Health™ is working to create a new category of products, services and data systems that have the potential to significantly improve the effectiveness of existing pharmaceutical treatments. Called digital medicines, these new pharmaceuticals will contain a tiny sensor that communicates with a patch to deliver vital information about an individual’s medication-taking behaviour and how their body is responding to therapy.

“The technology platform Proteus offers will allow digital health to become a reality, giving patients a role in managing their disease and allowing the management of chronic disease and drug compliance to be delivered in a much more cost effective way,” said Sir John Bell, Regius Professor of Medicine, Oxford University. “Oxford University and the Oxford Academic Health Science Network look forward to collaborating with Proteus to bring these exciting technologies to patients and improve their health.”

“Some patients have trouble taking their medicines for a host of different reasons, which may result in decreased effect of the therapy and unnecessary costs,” said Dr. Robert Winter, Managing Director, EAHSN. “Through this partnership, we will explore both the clinical and economic value of digital health technology in the treatment of hypertension.”

Andrew Thompson, President and Chief Executive Officer of Proteus Digital Health™, said: “This marks an important milestone in the emergence of the global digital medicines industry. We are honoured to be working with leaders who are positioning the UK and NHS at the forefront of digital innovation in healthcare by delivering tools that empower patients and their families.”

“This is fantastic news for Proteus Digital Health™ and for the UK,” said Dr. Mark Treherne, Chief Executive Officer of UKTI’s LSIO. “This move signifies a new economic opportunity and the growing momentum of transformational healthcare technology in the UK. Having a company of Proteus Digital Health™ calibre operating in the UK is a huge testament to the life science ecosystem and the global lead that the UK takes in supporting the adoption of new innovative products.”

About the Northern Health Science Alliance

The Northern Health Science Alliance Ltd (NHSA) is a new partnership established by the leading Universities and NHS Hospital Trusts in the North of England to improve the health and wealth of the region by creating an internationally recognized life science and healthcare system. The company acts as focal point for NHSA members, including the four Academic Health Science Networks in the North of England and partner organisations to work collaboratively on projects that leverage the combined potential of the North. The NHSA supports its partners in working together to harness the resources, infrastructure, intellectual capital and experience of the whole Northern healthcare ecosystem.

Further information is available at: www.theNHSA.co.uk

Oxford University Hospitals NHS Trust (OUH)

Oxford University Hospitals NHS Trust (OUH) is one of the largest acute teaching trusts in the UK, with a national and international reputation for the excellence of its services and its role in patient care, teaching and research. The Trust supports world-leading research programmes. It works in close partnership with the University of Oxford and is a leading centre for cancer, neurosciences, diabetes, genetics and many other fields. Research themes of particular strength are: cancer, cardiovascular science, diabetes, endocrinology & metabolism, infection and immunology, musculoskeletal science, neuroscience and reproduction and development. The Trust has been designated as a major trauma centre and is one of four UK centres for craniofacial surgery. The Trust employs 11,000 staff and consists of four hospitals: the Churchill Hospital, John Radcliffe Hospital and Nuffield Orthopaedic Centre in Oxford and the Horton General Hospital in Banbury.

Further information is available at: www.ouh.nhs.uk

About Proteus Digital Health

Proteus Digital Health™ is pioneering a new category of products, services and data systems based on ingestible computing. Its core technology – the digital health feedback system – provides an unprecedented view into an individual’s personal health choices and physiologic response, allowing patients to better manage their health and more effectively collaborate with caregivers and clinicians, while enabling new information-based business models. Proteus has received a CE mark in Europe and FDA market clearance in the U.S. for its wearable and Ingestible Sensor™ devices. Headquartered in Redwood City, Calif., Proteus is privately held and funded by Carlyle, Essex Woodlands, Kaiser Permanente®, Medtronic®, Novartis®, Otsuka®, Oracle®, ON Semiconductor® and other investors.

Further information is available at: www.proteus.com

Eastern Academic Health Science Network

The EAHSN has been set up to promote the adoption, diffusion and spread of innovation into and throughout the NHS. Our aim is to use innovation to reduce unwarranted variation in service provision and to help build the new paradigms for an improved health service for the next generation. Drawing on this, and our successful innovation hub and Small Business Research Initiative (SBRI) programmes, we will grow wealth and economic value, leveraging sustainable improvements in healthcare. The EAHSN will improve health outcomes, bridging the vital gap between world-class research and top-quality clinical care. Delivery is dependent on a transformational model based on four established biomedical and clinical communities, with a track record of excellence in research, education, health services and industry.

About UKTI LSIO

UK Trade & Investment (UKTI) is the government department that helps UK-based companies trade in the global economy and assists overseas companies bring their high-quality investment to the UK. UKTI has established a dedicated unit focused on UK life science - the UKTI Life Science Investment Organisation (LSIO). The LSIO works with overseas companies to identify research, development and delivery partners and provides support in every element of investing and working in the UK.

Further information is available at: www.ukti.gov.uk

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Choosing the right cloud for your workloads is a balancing act that can cost your organization time, money and aggravation - unless you get it right the first time. Economics, speed, performance, accessibility, administrative needs and security all play a vital role in dictating your approach to the cloud. Without knowing the right questions to ask, you could wind up paying for capacity you'll never need or underestimating the resources required to run your applications.
SYS-CON Events announced today that LeaseWeb USA, a cloud Infrastructure-as-a-Service (IaaS) provider, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LeaseWeb is one of the world's largest hosting brands. The company helps customers define, develop and deploy IT infrastructure tailored to their exact business needs, by combining various kinds cloud solutions.
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
SYS-CON Events announced today that 910Telecom will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and ...
StackIQ has announced the release of Stacki 3.2. Stacki is an easy-to-use Linux server provisioning tool. Stacki 3.2 delivers new capabilities that simplify the automation and integration of site-specific requirements. StackIQ is the commercial entity behind this open source bare metal provisioning tool. Since the release of Stacki in June of 2015, the Stacki core team has been focused on making the Community Edition meet the needs of members of the community, adding features and value, while ...
Big Data, cloud, analytics, contextual information, wearable tech, sensors, mobility, and WebRTC: together, these advances have created a perfect storm of technologies that are disrupting and transforming classic communications models and ecosystems. In his session at @ThingsExpo, Erik Perotti, Senior Manager of New Ventures on Plantronics’ Innovation team, provided an overview of this technological shift, including associated business and consumer communications impacts, and opportunities it ...
SYS-CON Events announced today that Venafi, the Immune System for the Internet™ and the leading provider of Next Generation Trust Protection, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Venafi is the Immune System for the Internet™ that protects the foundation of all cybersecurity – cryptographic keys and digital certificates – so they can’t be misused by bad guys in attacks...
Security, data privacy, reliability, and regulatory compliance are critical factors when evaluating whether to move business applications from in-house, client-hosted environments to a cloud platform. Quality assurance plays a vital role in ensuring that the appropriate level of risk assessment, verification, and validation takes place to ensure business continuity during the migration to a new cloud platform.
It’s 2016: buildings are smart, connected and the IoT is fundamentally altering how control and operating systems work and speak to each other. Platforms across the enterprise are networked via inexpensive sensors to collect massive amounts of data for analytics, information management, and insights that can be used to continuously improve operations. In his session at @ThingsExpo, Brian Chemel, Co-Founder and CTO of Digital Lumens, will explore: The benefits sensor-networked systems bring to ...
Deploying applications in hybrid cloud environments is hard work. Your team spends most of the time maintaining your infrastructure, configuring dev/test and production environments, and deploying applications across environments – which can be both time consuming and error prone. But what if you could automate provisioning and deployment to deliver error free environments faster? What could you do with your free time?
"We formed Formation several years ago to really address the need for bring complete modernization and software-defined storage to the more classic private cloud marketplace," stated Mark Lewis, Chairman and CEO of Formation Data Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Cloud analytics is dramatically altering business intelligence. Some businesses will capitalize on these promising new technologies and gain key insights that’ll help them gain competitive advantage. And others won’t. Whether you’re a business leader, an IT manager, or an analyst, we want to help you and the people you need to influence with a free copy of “Cloud Analytics for Dummies,” the essential guide to this explosive new space for business intelligence.
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, discussed how leveraging the Industrial Internet a...
Ixia (Nasdaq: XXIA) has announced that NoviFlow Inc.has deployed IxNetwork® to validate the company’s designs and accelerate the delivery of its proven, reliable products. Based in Montréal, NoviFlow Inc. supports network carriers, hyperscale data center operators, and enterprises seeking greater network control and flexibility, network scalability, and the capacity to handle extremely large numbers of flows, while maintaining maximum network performance. To meet these requirements, NoviFlow in...
There will be new vendors providing applications, middleware, and connected devices to support the thriving IoT ecosystem. This essentially means that electronic device manufacturers will also be in the software business. Many will be new to building embedded software or robust software. This creates an increased importance on software quality, particularly within the Industrial Internet of Things where business-critical applications are becoming dependent on products controlled by software. Qua...